BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 8510932)

  • 1. Mitogenesis of quiescent chick fibroblasts by v-Src: dependence on events at the membrane leading to early changes in AP-1.
    Catling AD; Wyke JA; Frame MC
    Oncogene; 1993 Jul; 8(7):1875-86. PubMed ID: 8510932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitogenesis by v-Src: fluctuations throughout G1 of classical immediate early AP-1 and mitogen-activated protein kinase responses that parallel the need for the oncoprotein.
    Wyke AW; Frame MC; Gillespie DA; Chudleigh A; Wyke JA
    Cell Growth Differ; 1995 Oct; 6(10):1225-34. PubMed ID: 8845299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functions of the v-Src protein tyrosine kinase.
    Fincham V; Frame M; Haefner B; Unlu M; Wyke A; Wyke J
    Cell Biol Int; 1994 May; 18(5):337-44. PubMed ID: 8049678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitogenesis induced by pp60v-src is not accompanied by increased expression of immediate early response genes.
    Welham MJ; Wyke JA; Lang A; Wyke AW
    Oncogene; 1990 Feb; 5(2):161-9. PubMed ID: 2108404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo viral and cellular Jun complexes exhibit differential interaction with a number of in vitro generated 'AP-1- and CREB-like' target sequences.
    Hadman M; Loo M; Bos TJ
    Oncogene; 1993 Jul; 8(7):1895-903. PubMed ID: 8510933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylation and high level expression of Fra-2 in v-src transformed cells: a pathway of activation of endogenous AP-1.
    Murakami M; Sonobe MH; Ui M; Kabuyama Y; Watanabe H; Wada T; Handa H; Iba H
    Oncogene; 1997 May; 14(20):2435-44. PubMed ID: 9188858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The v-Jun oncoprotein replaces p39 c-Jun as the predominant AP-1 constituent in ASV17-transformed fibroblasts: implications for SAPK/JNK-mediated signal transduction.
    Kilbey A; Black EJ; Unlu M; Gillespie DA
    Oncogene; 1996 Jun; 12(11):2409-18. PubMed ID: 8649782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-fos is a positive regulator of carcinogen enhancement of adenovirus transformation.
    Su ZZ; Yemul S; Stein CA; Fisher PB
    Oncogene; 1995 May; 10(10):2037-49. PubMed ID: 7761104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variations in Jun and Fos protein expression and AP-1 activity in cycling, resting and stimulated fibroblasts.
    Lallemand D; Spyrou G; Yaniv M; Pfarr CM
    Oncogene; 1997 Feb; 14(7):819-30. PubMed ID: 9047389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. fra-2 promoter can respond to serum-stimulation through AP-1 complexes.
    Sonobe MH; Yoshida T; Murakami M; Kameda T; Iba H
    Oncogene; 1995 Feb; 10(4):689-96. PubMed ID: 7862446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. v-Src-induced degradation of focal adhesion kinase during morphological transformation of chicken embryo fibroblasts.
    Fincham VJ; Wyke JA; Frame MC
    Oncogene; 1995 Jun; 10(11):2247-52. PubMed ID: 7784071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired induction of c-fos/c-jun genes and of transcriptional regulatory proteins binding distinct c-fos/c-jun promoter elements in activated human T cells during aging.
    Whisler RL; Chen M; Beiqing L; Carle KW
    Cell Immunol; 1997 Jan; 175(1):41-50. PubMed ID: 9015187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73.
    Smeal T; Binetruy B; Mercola DA; Birrer M; Karin M
    Nature; 1991 Dec; 354(6353):494-6. PubMed ID: 1749429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
    Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
    Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure and transcriptional regulation of BKJ, a novel AP-1 target gene activated during jun- or fos-induced fibroblast transformation.
    Hartl M; Bister K
    Oncogene; 1998 Dec; 17(22):2901-13. PubMed ID: 9879996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning and characterization of a thermolabile v-src gene for use in reversible transformation of mammalian cells.
    Maroney AC; Qureshi SA; Foster DA; Brugge JS
    Oncogene; 1992 Jun; 7(6):1207-14. PubMed ID: 1375718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular targeting of pp60src expression: localization of v-src to adhesion plaques is sufficient to transform chicken embryo fibroblasts.
    Liebl EC; Martin GS
    Oncogene; 1992 Dec; 7(12):2417-28. PubMed ID: 1334249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytochrome P4502E1- and cytochrome P4502B1/2B2-catalyzed carbon tetrachloride metabolism: effects on signal transduction as demonstrated by altered immediate-early (c-Fos and c-Jun) gene expression and nuclear AP-1 and NF-kappa B transcription factor levels.
    Gruebele A; Zawaski K; Kaplan D; Novak RF
    Drug Metab Dispos; 1996 Jan; 24(1):15-22. PubMed ID: 8825185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of c-fos and c-jun proteins and AP-1 binding activity during cell cycle progression of HL60 cells and phytohemagglutinin-stimulated lymphocytes.
    Tay DL; Hoffbrand AV; Wickremasinghe GR
    Exp Hematol; 1996 Feb; 24(2):277-84. PubMed ID: 8641353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Directed mutation of the basic domain of v-Jun alters DNA binding specificity and abolishes its oncogenic activity in chicken embryo fibroblasts.
    Basso J; Briggs J; Findlay C; Bos T
    Oncogene; 2000 Oct; 19(42):4876-85. PubMed ID: 11039905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.